TEDA BIOMEDICAL: ANNOUNCEMENT ON ANNUAL RESULTS FOR 2025

HKEXMar 31 10:57 ET · Announcements

Teda Bio (08189) issues a profit warning, expecting an annual loss attributable to shareholders of approximately RMB 85 million.

Teda Bio (08189) announced that the group expects to record a loss attributable to shareholders of approximately RMB 85 million for the year ended December 31, 2025, compared to a loss attributable to shareholders of RMB 27.8022 million for the year ended December 31, 2024.

Zhitong FinanceMar 29 06:10 ET

TEDA BIOMEDICAL: PROFIT WARNING

HKEXMar 29 06:08 ET · Announcements

Zhitong HK Stock Investment Diary | December 30

Hong Kong Stock Investment Diary | December 30, 2025

Zhitong FinanceDec 29, 2025 11:00 ET

Teda Bio (08189): Li Xueying and Wang Yongkang will step down as directors of the company.

Teda Bio (08189) announced that Ms. Li Xueying, non-executive director, and Mr. Wang Yongkang, independent non-executive director, will step down upon the approval of the appointment of the ninth board of directors at the company’s extraordinary general meeting of shareholders. Mr. Wang Yongkang will also step down as a member and chairman of the Remuneration Committee, a member of the Nomination Committee, and a member of the Audit Committee.

Zhitong FinanceDec 12, 2025 04:11 ET

Some Confidence Is Lacking In Tianjin TEDA Biomedical Engineering Company Limited (HKG:8189) As Shares Slide 28%

Simply Wall StDec 8, 2025 17:07 ET